Hybrid recombinant human leukocyte interferon inhibits differentiation in murine B-16 melanoma cells

We have investigated the effects of recombinant human leukocyte interferons (IFN-alpha A and IFN-alpha D) and various hybrid recombinant human leukocyte interferons on differentiation in B-16 mouse melanoma cells. Inhibition of both spontaneous and melanocyte hormone stimulated differentiation was observed with one hybrid construct, IFN-alpha A/D (Bgl) consisting of amino acids 1 to 62 from IFN-alpha A and amino acids 64 to 166 from IFN-alpha D. In contrast, the parental human interferons, IFN-alpha A and IFN-alpha D, when used alone or in combination, as well as other hybrid human leukocyte interferons, did not cause significant inhibition of melanogenesis in B-16 mouse cells. The tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) also inhibited B-16 differentiation and the combination of TPA with IFN-alpha A/D (Bgl) or mouse L-cell interferon was synergistic in delaying melanogenesis. These studies indicate that the IFN-alpha A/D (Bgl) hybrid that exhibits antiviral activity on mouse cells can also inhibit differentiation of murine cells.     

DNA polymorphism of Pvu II site in the lipoprotein lipase gene in patients with non-insulin dependent diabetes mellitus

We studied the effect of variation at the lipoprotein lipase (LPL) gene locus on the susceptibility of individuals with non-insulin dependent diabetes mellitus (NIDDM) in a population of 110 NIDDM patients and 91 controls. Our objective was to study the relationship between the LPL-Pvu II polymorphism and NIDDM and lipid metabolism. PCR-RFLP was used to determine the DNA polymorphism of the sixth intron of the LPL gene. The frequencies of the genotypes in case and control groups were 29.1 and 30.8% for P+/P+; 45.5 and 36.3% for P+/P-; 25.5 and 33% for P-/P- respectively. There was no significant difference in frequencies of genotypes between the two groups. Logistic regression analysis revealed that triacylglycerol (TAG) and apolipoprotein E levels were associated with NIDDM, whereas Pvu II genotypes were not found as independent risk factors for the disease. Overall this study demonstrates the role of the Pvu II polymorphism in the LPL gene in modulating plasma lipid/lipoprotein levels in patients with NIDDM.     

识别序列外DNA甲基化对限制性核酸内切酶PvuⅡ酶切活性影响的研究

构建了重组质粒ｐＳＶ２ｇｐｔ－ＳＶ４０ｏｒｉ－ａｎｔｉｓｅｎｓｅ－ｒａｓ（简称Ｐ１）,利用这一重组体进一步证实了识别序列外ＤＮＡ甲基化对限制性核酸内切酶ＰｖｕⅡ切割活性的抑制作用,并对这一抑制作用进行了定量研究。结果表明：邻近ＰｖｕⅡ识别位,点的ＤＮＡ甲基化可降低ＰｖｕⅡ对该位点酶切活性的７０％左右。     

猪雌激素受体基因Pvu II多态性与产仔数性状的关系

雌激素受体（estrogen receptor,ESR）能调控雌激素的合成,影响繁殖功能。将ESR基因作为控制猪产仔数的候选基因,分析其Pvu II多态性与高产猪种莱芜猪和国外引进猪种长白猪产仔数的关系。序列分析发现,PCR扩增区56bp的Pvu II酶切片段位于RFLP分析获得的37kb正向序列的起始部分。因ESR基因在高产仔数的莱芜猪中的Pvu II多态性分布不能证实B基因为优势基因,故推测37kb条带对该猪种产仔数可能不起决定作用。 Abstract:Estrogen receptor (ESR) can regulate the synthesis of oestrogen and affect the reproduction of swine.The relationship between PvuII polymorphisms at estrogen receptor gene and litter size was analyzed in Laiwu breed and Landrace breed by candidate gene method.The results were shown that 56bp of PvuII polymorphisms was the same as the beginning sequence of 37kb of RFLP.The distribution of PvuII polymorphisms also could not prove that B gene was a superior gene,and there was no decisive effect of 37kb band on litter size in pigs.